ACATHIA-CAPITAL
Benelux Life Run-Off SCS announced today the completion of its acquisition of ABN AMRO Life Capital Belgium N.V. (“AALCB”), the Belgian life insurance subsidiary of ABN AMRO, after having received the relevant regulatory approvals.
Benelux Life Run-Off SCS was established by Acathia Capital as the first run-off platform for life insurance companies and life insurance portfolios based in Belgium, with AALCB being its first acquisition.
Monument Re as sole investor has full ownership over Benelux Life Run-Off SCS and AALCB with the purpose of further unlocking the potential of the company in the Belgian market. AALCB will be renamed into Monument Assurance Belgium N.V.
Thomas Schmitt, Managing Partner of Acathia Capital said: “After having already implemented a life run-off platform in Germany, this success demonstrates that the business model life run-off also works in other Continental European markets. It adds further to Acathia’s unique track record of providing trouble-free exit solutions to insurers with maximum transaction certainty.”
About Monument Re
Monument Re Limited (“Monument Re”) was
established in 2016 and is licensed by the Bermuda Monetary Authority as
a Class E reinsurer. Monument Re acts as a reinsurer and acquirer of
asset-intensive European insurers looking to improve their capital
efficiency through a strategy of reinsurance and/or acquisition.
To learn more, please visit www.monumentregroup.com .
About Acathia Capital
Acathia Capital GmbH is an investment
firm specialized on the European financial services sector. It has a
strong track record in insurance run-off, both in life and non-life.
Acathia lead managed among others: the acquisition of DARAG from AIG,
today a leading German life run-off platform after the acquisitions of
the German branch of Baloise, ARAG Leben and a German pension fund of
AXA; and the acquisition of Ageas Lebensversicherung from Ageas
Insurance, today active as MyLife in Germany.
To learn more, please visit www.acathia.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20180328005866/en/
Contact:
Acathia Capital
Theda Hohn
E-Mail: theda.hohn@acathia.com
Phone:
+49 69 742225 70
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting samarbejder med MJB Technology Solutions om at fremme digitale transformationsmuligheder7.9.2025 08:24:00 CEST | Pressemeddelelse
Andersen Consulting styrker sin platform for digital transformation gennem et samarbejde med det canadiske firma MJB Technology Solutions, der er specialiseret i ServiceNow, kunstig intelligens, analyse og IT-transformation. MJB Technology Solutions blev stiftet i 2002 og udvikler skræddersyet software, digitale platforme og operationelle systemer til kunder inden for sektorer som banker, telekommunikation og produktion. Virksomhedens kernekompetencer omfatter komplekse ServiceNow-tjenester samt AI-baserede løsninger, business intelligence og analyse samt digital IT-strategi – og de leverer konsekvent målbare resultater og langsigtet værdi. "Gennem to årtier har vi leveret specialudviklede løsninger, der hjælper vores kunder med at tackle forretningskritiske udfordringer," siger Mark Bains, administrerende direktør hos MJB Technology Solutions. "Vores samarbejde med Andersen Consulting markerer et nyt kapitel i, hvordan vi skalerer innovation globalt, samtidig med at vi forbliver tro m
U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease6.9.2025 02:45:00 CEST | Press release
− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce the Frequency of Bleeding Episodes in Adults with Type 1 and 2 Von Willebrand Disease (VWD) and On-Demand and Perioperative Management of Bleeding in Pediatric Patients with VWD1 − VONVENDI is the Only Recombinant Von Willebrand Factor Replacement Therapy with Approved Indications in Adults and Children with VWD1 − VWD, the Most Common Bleeding Disorder, Impacts More Than 3 Million People in the U.S.2 Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for VONVENDI® [von Willebrand factor (Recombinant)], expanding the indication to include routine prophylaxis to reduce the frequency of bleeding episodes in adults with von Willebrand Disease (VWD), including those with Type 1 and 2 disease, and on-demand and perioperative management of bleeding in pediatric patients with VWD. VONVENDI was previously approve
Samsung Unveils “AI Home: Future Living, Now” Vision at IFA 20255.9.2025 23:34:00 CEST | Press release
From well-being to energy efficiency, Bespoke AI, Vision AI, and Galaxy AI transform the way we live and connect. At Innovation For All (IFA) 2025, Samsung Electronics showcased its vision for “AI Home: Future Living, Now”. Samsung’s AI Home aims to be a reality people can experience today — not just in the future — and one designed for everyone, not just a select few. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250905654772/en/ Cheolgi Kim, Head of Digital Appliances, presents Future Living Now at Samsung’s IFA 2025 press conference in Berlin “At Samsung, we’re not just imagining the future of AI; we’re building it into everyday life. Samsung’s AI Home moves beyond smart devices to homes that truly understand you, adapt to your needs, and care for what matters most,” said Cheolgi Kim (CK), Executive Vice President and Head of Digital Appliances (DA) Business. “This is the beginning of a new era - where technology support
Andersen Consulting styrker end-to-end-teknologikompetencer via samarbejde med FirstQA Systems5.9.2025 19:44:00 CEST | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation og kunstig intelligens via en samarbejdsaftale med FirstQA Systems, der er en førende teknologileverandør, som er kendt for sin ekspertise inden for AI til virksomheder, digital transformation og cybersikkerhed. FirstQA Systems K.K. med hovedsæde i Japan siden 2011 er en konsulentdrevet teknologivirksomhed, der betjener Fortune 500-virksomheder og multinationale koncerner i Asien, Europa og Nordamerika. Virksomheden specialiserer sig i kunstig intelligens, digital transformation (med fokus på platformene ServiceNow, SAP og Salesforce) samt it- og OT-cybersikkerhed. Gennem sit datterselskab, Himitsu Lab Limited, leverer FirstQA Systems banebrydende Agentic AI-løsninger drevet af HIMITSU8™ Unified Development Framework (UDF)™. Virksomhedens brancheekspertise dækker bl.a. produktion, medicinalindustrien samt løsninger til bank- og finansverdenen. "Vores samarbejde med Andersen Consulting markerer et spændende sk
NetApp named a Leader by Gartner® in the 2025 Magic Quadrant™ for Enterprise Storage Platforms5.9.2025 17:15:00 CEST | Press release
Recognition reflects NetApp’s Ability to Execute and Completeness of Vision NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced it has been recognized by Gartner as a Leader in the 2025 Gartner Magic Quadrant for Enterprise Storage Platforms. NetApp believes this recognition reflects how the company’s continuous innovation helps customers build Intelligent Data Infrastructure to face modern technology challenges, including protection from cyber threats and using AI to drive data-based decisions. The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute. According to Gartner, “Enterprise storage platforms offer platform-native service capabilities and product features for both structured and unstructured data workloads. Heads of infrastructure and operations should use this research to assess vendors in deploying a modern IT infrastructure platform for block, file and object storage.”
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom